MedTrace Logo

Heart Rate Regularization in Patients With Permanent Atrial Fibrillation Post Marketing Study

NCT00246805 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2011-09-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to monitor heart rate regularization in patients with permanent atrial fibrillation and standard indication for single chamber rate adaptive pacing VVI(R).

Conditions

  • Permanent Atrial Fibrillation

Interventions

DEVICE

Vitatron pacemaker C20 SSIR or T20 SSIR models

VRS: special function that automatically adapts pacing rate to regularize cardiac cycles

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Medtronic BRC

    lead INDUSTRY

Principal Investigators

  • Giorgio Corbucci, PhD · Vitatron Medical Italia

  • Eraldo Occhetta, MD · Ospedale Maggiore della Misericordia - Novara

  • Gianfranco Mazzocca, MD · Ospedale di Cecina (LI)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2009-01-31
Completion
2009-03-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00246805 on ClinicalTrials.gov